TrialArthritis research & therapy2009

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis.

Désirée M van der Heijde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.